speb/financial-data huggingface dataset:
Financial ratios for AARTIPHARM.NS — annual report dated 2025-03-31
Total revenue: 247261456.6284779
Gross profit: 121396013.56090717
Operating income: 44127507.59878419
Net income: 31845312.134673834
Capital expenditures: 46999929.857376665
Operating cash flow: 38594739.30324994
Depreciation & amortization: 10159457.563712882
Net tangible assets: 220912590.60088846
Owner earnings: -4995160.158989951
Return on net tangible assets (%): -2.261147789450558
Capex to operating income (%): 106.50936890591937
Buffett classification: The Gruesome
Stock price: 8.701715486054383
P/E ratio: 24.778213186218384
Shares outstanding: 90679813
Book value: 232628758.47556692
P/B ratio: 3.3919707014104703
Market cap (USD): 789069933.0546155
Debt to equity: 0.21147622822862427
Current ratio: 2.012279440133506
Quick ratio: 1.1180099825051233
Effective tax rate (%): 24.47664819741079
Interest coverage ratio: 14.03409750003718
COGS to revenue (%): 50.9037861314105
R&D to revenue (%): 1.5522904748745256
SG&A to revenue (%): 4.478400169828533
Free cash flow (dilution-adjusted): -13296574.70189385
Buyback yield (%): 0
Retained earnings: 154700900.1636661
Inventory turnover: 1.832353522324561
Receivables turnover: 3.675803308523549
Capitalized R&D asset: 5071855.462231093
ROCI (R&D-adjusted, %): 17.081931409116642
Rosenberg metric: 37.02208540930275
FCF margin (%): -5.377536346828444
Revenue growth (%): 13.572425285528086
Rule of 40 score: 8.194888938699641
Financial ratios for AARTIPHARM.NS — quarterly report dated 2025-03-31
Total revenue: 65907996.259060085
Gross profit: 35553647.416413374
Operating income: 14357072.714519521
Net income: 10327425.765723638
Capital expenditures: 0
Depreciation & amortization: 2667266.775777414
Net tangible assets: 220912590.60088846
Owner earnings: 12994692.541501053
Return on net tangible assets (%): 5.88227792094381
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.701715486054383
P/E ratio: 19.101321833595524
Shares outstanding: 90679813
Book value: 232628758.47556692
P/B ratio: 3.3919707014104703
Market cap (USD): 789069933.0546155
Debt to equity: 0.21147622822862427
Current ratio: 2.012279440133506
Quick ratio: 1.1180099825051233
Effective tax rate (%): 22.92703610286888
Interest coverage ratio: 18.654838758677258
COGS to revenue (%): 46.05563902039282
Buyback yield (%): 0
Retained earnings: 154700900.1636661
Inventory turnover: 0.441899672095324
Receivables turnover: 0.9797921358654178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.459803687776179
Rule of 40 score: 0
Financial ratios for AARTIPHARM.NS — quarterly report dated 2025-06-30
Total revenue: 45189667.680786334
Gross profit: 25366896.793821674
Operating income: 8477662.064123567
Net income: 5792335.595600281
Capital expenditures: 0
Depreciation & amortization: 2667002.1062485375
Owner earnings: 8459337.701848818
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.36824245260941
P/E ratio: 40.57906656234787
Shares outstanding: 90679813
Market cap (USD): 940190286.7412827
Effective tax rate (%): 24.373192452184487
Interest coverage ratio: 10.662423288054276
COGS to revenue (%): 43.86571511653952
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -31.435227520553994
Rule of 40 score: -31.435227520553994
Financial ratios for AARTIPHARM.NS — quarterly report dated 2025-09-30
Total revenue: 47162886.133032694
Gross profit: 23512807.215332583
Operating income: 5631285.231116122
Net income: 3148038.3314543404
Capital expenditures: 0
Depreciation & amortization: 2792468.9966178127
Net tangible assets: 217777869.22209695
Owner earnings: 5940507.328072153
Return on net tangible assets (%): 2.727782831787114
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.311161217587372
P/E ratio: 43.82100558893288
Shares outstanding: 90679813
Book value: 230688342.72829765
P/B ratio: 3.6600651252591616
Market cap (USD): 844334358.0236752
Debt to equity: 0.32195093200800545
Current ratio: 1.6361473267584696
Quick ratio: 0.8705775042541376
Effective tax rate (%): 27.832741482779472
Interest coverage ratio: 4.6834095938191505
COGS to revenue (%): 50.145529370255595
Buyback yield (%): 0
Inventory turnover: 0.3380280192243423
Receivables turnover: 0.8899168870178245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0343692510420084
Revenue growth (%): 4.366525698274453
Rule of 40 score: 4.366525698274453
Financial ratios for AARTIPHARM.NS — quarterly report dated 2025-12-31
Total revenue: 48153358.583045565
Gross profit: 28920240.614904758
Operating income: 8208833.686086666
Net income: 5342051.910437786
Capital expenditures: 0
Depreciation & amortization: 3187891.2777097025
Owner earnings: 8529943.188147489
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.363707251865879
P/E ratio: 30.817715678010458
Shares outstanding: 90679813
Market cap (USD): 758419409.5859418
Effective tax rate (%): 23.721146260148117
Interest coverage ratio: 5.857952558109956
COGS to revenue (%): 39.94138422343118
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.1001099195223913
Rule of 40 score: 2.1001099195223913
Financial ratios for ABSLAMC.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.451931953052882
Shares outstanding: 289263746
Market cap (USD): 1866310005.677173
Buyback yield (%): 0
Retained earnings: 262033284.97955954
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABSLAMC.NS — annual report dated 2023-03-31
Total revenue: 149404384.89646775
Gross profit: 118768574.908648
Operating income: 81773447.01583436
Net income: 72640682.0950061
Capital expenditures: 2271619.9756394643
Operating cash flow: 53271619.97563947
Depreciation & amortization: 4180267.96589525
Net tangible assets: 305382460.41412914
Owner earnings: 74549330.08526188
Return on net tangible assets (%): 24.41179168710788
Capex to operating income (%): 2.777943279313632
Buffett classification: The Great
Stock price: 3.5723507917174184
P/E ratio: 14.225521322703646
Shares outstanding: 289263746
Book value: 306576126.67478687
P/B ratio: 3.37061983020751
Market cap (USD): 1033351572.0382463
Debt to equity: 0.019082316576545796
Current ratio: 9.029193767962488
Quick ratio: 9.029193767962488
Effective tax rate (%): 24.875922706774492
Interest coverage ratio: 172.14358974358976
COGS to revenue (%): 20.505295081566267
SG&A to revenue (%): 6.55138960223706
Free cash flow (dilution-adjusted): 47163215.590743
Buyback yield (%): 0
Retained earnings: 276449451.88794154
Receivables turnover: 50.00448430493274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.923337413458235
FCF margin (%): 31.567490889524784
Rule of 40 score: 31.567490889524784
Financial ratios for ABSLAMC.NS — annual report dated 2024-03-31
Total revenue: 162272454.73078308
Gross profit: 123840988.1280729
Operating income: 87286245.35315984
Net income: 93579565.89519127
Capital expenditures: 3607147.1399448374
Operating cash flow: 82124955.03057921
Depreciation & amortization: 4149178.5585801653
Net tangible assets: 378544189.95083344
Owner earnings: 94121597.31382659
Return on net tangible assets (%): 24.864097722924082
Capex to operating income (%): 4.132549321316701
Buffett classification: The Great
Stock price: 5.2107725527831095
P/E ratio: 16.10701624604864
Shares outstanding: 289263746
Book value: 380007195.10732704
P/B ratio: 3.9664711815425373
Market cap (USD): 1507287588.172025
Debt to equity: 0.024958344904193276
Current ratio: 9.917589699895862
Quick ratio: 9.917589699895862
Effective tax rate (%): 22.594851956554084
Interest coverage ratio: 129.28596802841918
COGS to revenue (%): 23.683296506772884
SG&A to revenue (%): 5.924519099313473
Free cash flow (dilution-adjusted): 75670943.7582444
Buyback yield (%): 0
Retained earnings: 347545269.2169325
Receivables turnover: 33.22342253866929
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.120045341412936
FCF margin (%): 46.63203245663949
Revenue growth (%): 8.612913097050313
Rule of 40 score: 55.2449455536898
Financial ratios for ABSLAMC.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 389085045.3893932
Buffett classification: The Gruesome
Stock price: 8.358456760630673
Shares outstanding: 289263746
Book value: 390715480.1720019
P/B ratio: 6.188130842153179
Market cap (USD): 2417798513.359054
Debt to equity: 0.022943562809722814
Current ratio: 2.0893527204502815
Quick ratio: 2.0893527204502815
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABSLAMC.NS — quarterly report dated 2024-12-31
Total revenue: 51883669.42534094
Gross profit: 40213311.574775614
Operating income: 30678400.746007692
Net income: 26165054.20212146
Capital expenditures: 0
Depreciation & amortization: 1298519.6409837976
Owner earnings: 27463573.843105257
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.492598204918988
P/E ratio: 26.23599109346683
Shares outstanding: 289263746
Market cap (USD): 2745864516.027742
Effective tax rate (%): 25.15171723907969
Interest coverage ratio: 153.0174418604651
COGS to revenue (%): 22.493316258902293
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABSLAMC.NS — annual report dated 2025-03-31
Total revenue: 196958148.23474395
Gross profit: 150446574.70189384
Operating income: 111095393.96773438
Net income: 108791208.79120879
Capital expenditures: 3537526.30348375
Operating cash flow: 82824409.63292027
Depreciation & amortization: 4653963.058218377
Net tangible assets: 433875379.9392097
Owner earnings: 109907645.54594341
Return on net tangible assets (%): 25.331616087859736
Capex to operating income (%): 3.1842240952952197
Buffett classification: The Great
Stock price: 7.231532267475784
P/E ratio: 19.227841442818452
Shares outstanding: 289263746
Book value: 435687397.70867425
P/B ratio: 4.8011949026091205
Market cap (USD): 2091820113.0099194
Debt to equity: 0.018261973183931825
Current ratio: 10.981980236388297
Quick ratio: 10.981980236388297
Effective tax rate (%): 25.225384479406042
Interest coverage ratio: 167.89929328621906
COGS to revenue (%): 23.6149526941203
SG&A to revenue (%): 5.316421135103694
Free cash flow (dilution-adjusted): 78490764.55459434
Buyback yield (%): 0
Retained earnings: 401834229.600187
Receivables turnover: 29.113184724382233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.64254041354846
FCF margin (%): 39.85149396360356
Revenue growth (%): 21.374973073221774
Rule of 40 score: 61.22646703682533
Financial ratios for ABSLAMC.NS — quarterly report dated 2025-03-31
Total revenue: 50133270.98433481
Gross profit: 37156885.667523965
Operating income: 27376665.887304183
Net income: 26663549.216740705
Capital expenditures: 0
Depreciation & amortization: 1139817.6291793312
Net tangible assets: 433875379.9392097
Owner earnings: 27803366.845920037
Return on net tangible assets (%): 6.4081457790519405
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.231532267475784
P/E ratio: 19.61310641736107
Shares outstanding: 289263746
Book value: 435687397.70867425
P/B ratio: 4.8011949026091205
Market cap (USD): 2091820113.0099194
Debt to equity: 0.018261973183931825
Current ratio: 10.981980236388297
Quick ratio: 10.981980236388297
Effective tax rate (%): 25.229478101232623
Interest coverage ratio: 212.89090909090908
COGS to revenue (%): 25.88377949818114
Buyback yield (%): 0
Retained earnings: 401834229.600187
Receivables turnover: 7.4104026265768095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.072534345681701
Revenue growth (%): -3.3736982376023015
Rule of 40 score: -3.3736982376023015
Financial ratios for ABSLAMC.NS — quarterly report dated 2025-06-30
Total revenue: 52350807.39527264
Gross profit: 39935642.40580389
Operating income: 29921600.74888837
Net income: 32425696.232155398
Capital expenditures: 0
Depreciation & amortization: 1201731.8043529138
Owner earnings: 33627428.036508314
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.109056868710509
P/E ratio: 30.9065926663651
Shares outstanding: 289263746
Market cap (USD): 2634919912.370232
Effective tax rate (%): 25.56409154399914
Interest coverage ratio: 195.19847328244273
COGS to revenue (%): 23.715326672478156
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.423282916510169
Rule of 40 score: 4.423282916510169
Financial ratios for ABSLAMC.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.923337091319052
P/E ratio: 30.27645437733515
Shares outstanding: 289263746
Market cap (USD): 2581197913.855693
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABSLAMC.NS — quarterly report dated 2025-12-31
Total revenue: 53256098.91946085
Gross profit: 39774980.50573689
Operating income: 30969143.36638075
Net income: 30023393.115740225
Capital expenditures: 0
Depreciation & amortization: 1302216.7762058594
Owner earnings: 31325609.891946085
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.970145928483904
P/E ratio: 29.117508528914822
Shares outstanding: 289263746
Market cap (USD): 2594738013.439902
Effective tax rate (%): 24.77182013565188
Interest coverage ratio: 224.20161290322582
COGS to revenue (%): 25.31375502008032
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTW — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 5201386
Market cap (USD): 18412906.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTW — annual report dated 2022-11-30
Total revenue: 25646152
Gross profit: 6938656
Operating income: 604718
Net income: 97797
Capital expenditures: 1669481
Operating cash flow: 951721
Depreciation & amortization: 661018
Net tangible assets: 11150637
Owner earnings: -910666
Return on net tangible assets (%): -8.166941494015095
Capex to operating income (%): 276.0759560654718
Buffett classification: The Gruesome
Stock price: 1.94
P/E ratio: 103.17994253402455
Shares outstanding: 5201386
Book value: 11150637
P/B ratio: 0.9049428153745835
Market cap (USD): 10090688.84
Debt to equity: 0.6639460149227349
Current ratio: 1.5250877575955601
Quick ratio: 0.4884622676599381
Effective tax rate (%): 15.154532094778475
Interest coverage ratio: 1.49613051352341
COGS to revenue (%): 72.94465072187047
R&D to revenue (%): 2.2636417346352777
SG&A to revenue (%): 22.433778759480173
Free cash flow (dilution-adjusted): -1005481
Buyback yield (%): 0.9160127862985418
Retained earnings: 6754284
Inventory turnover: 1.9473367984121095
Receivables turnover: 8.78986433130799
Capitalized R&D asset: 580537
ROCI (R&D-adjusted, %): 6.49830382150049
FCF margin (%): -3.9205920638698544
Rule of 40 score: -3.9205920638698544
Financial ratios for ARTW — annual report dated 2023-11-30
Total revenue: 30280957
Gross profit: 8583882
Operating income: 1531241
Net income: 266969
Capital expenditures: 841784
Operating cash flow: -55194
Depreciation & amortization: 804820
Net tangible assets: 11641255
Owner earnings: 230005
Return on net tangible assets (%): 1.9757749486631808
Capex to operating income (%): 54.9739720919176
Buffett classification: The Good
Stock price: 2.06
P/E ratio: 40.1352035629605
Shares outstanding: 5201386
Book value: 11641255
P/B ratio: 0.9204209649217374
Market cap (USD): 10714855.16
Debt to equity: 0.6997529905495584
Current ratio: 1.605689948816517
Quick ratio: 0.4315191138967941
Effective tax rate (%): 29.938883929063476
Interest coverage ratio: 2.5953017347310614
COGS to revenue (%): 71.65254057195088
R&D to revenue (%): 1.9750531662523083
SG&A to revenue (%): 21.315627508073803
Free cash flow (dilution-adjusted): -1189163
Buyback yield (%): 0.6396353378238293
Retained earnings: 7021253
Inventory turnover: 1.9668536849756177
Receivables turnover: 8.136765625025191
Capitalized R&D asset: 987024.79
ROCI (R&D-adjusted, %): 10.85673437322706
Rosenberg metric: 2.83397268391162
FCF margin (%): -3.927098473142708
Revenue growth (%): 18.072126375917914
Rule of 40 score: 14.145027902775206
Financial ratios for ARTW — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.07
Shares outstanding: 5201386
Market cap (USD): 10766869.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTW — annual report dated 2024-11-30
Total revenue: 24499371
Gross profit: 7309865
Operating income: 460697
Net income: 307375
Capital expenditures: 724679
Operating cash flow: 2626700
Depreciation & amortization: 989823
Net tangible assets: 12093823
Owner earnings: 572519
Return on net tangible assets (%): 4.733978660015117
Capex to operating income (%): 157.30056848644554
Buffett classification: The Gruesome
Stock price: 1.7
P/E ratio: 28.767323952826352
Shares outstanding: 5201386
Book value: 12093823
P/B ratio: 0.7311464869297326
Market cap (USD): 8842356.2
Debt to equity: 0.3955281138147962
Current ratio: 1.978789725070196
Quick ratio: 0.4216206485253735
Interest coverage ratio: 0.7686020594064692
COGS to revenue (%): 70.16305030851609
R&D to revenue (%): 1.765706556303017
SG&A to revenue (%): 26.190798939287053
Free cash flow (dilution-adjusted): 1719174
Buyback yield (%): 0.42583672437896136
Retained earnings: 7328628
Inventory turnover: 1.664373625145758
Receivables turnover: 9.473587925466857
Capitalized R&D asset: 1024867.76
ROCI (R&D-adjusted, %): 2.278639167604587
Rosenberg metric: -2.130231663782365
FCF margin (%): 7.017216890996917
Revenue growth (%): -19.093141607116316
Rule of 40 score: -12.075924716119399
Financial ratios for ARTW — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7
Shares outstanding: 5201386
Market cap (USD): 8842356.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTW — quarterly report dated 2025-02-28
Total revenue: 5140955
Gross profit: 1496509
Operating income: 2485
Net income: -55757
Capital expenditures: 82730
Operating cash flow: -101805
Depreciation & amortization: 238527
Net tangible assets: 12080743
Owner earnings: 100040
Capex to operating income (%): 3329.1750503018106
Buffett classification: The Gruesome
Stock price: 1.64
Shares outstanding: 5201386
Book value: 12080743
P/B ratio: 0.7061050003298638
Market cap (USD): 8530273.04
Debt to equity: 0.4113539208639734
Current ratio: 2.000389901159902
Quick ratio: 0.3261410879042474
Interest coverage ratio: 0.03283215304936053
COGS to revenue (%): 70.89044739741935
R&D to revenue (%): 1.6578631791174987
SG&A to revenue (%): 27.403352100922884
Free cash flow (dilution-adjusted): -228754
Buyback yield (%): 0.018076795347221383
Retained earnings: 7272871
Inventory turnover: 0.3349341545261767
Receivables turnover: 3.0320243790812667
Capitalized R&D asset: 85230
ROCI (R&D-adjusted, %): 0.4064563958746167
FCF margin (%): -4.449640193310387
Rule of 40 score: -4.449640193310387
Financial ratios for ARTW — quarterly report dated 2025-05-31
Total revenue: 6336690
Gross profit: 2059777
Operating income: 510654
Net income: 1482069
Capital expenditures: 130711
Operating cash flow: 1354178
Depreciation & amortization: 220317
Net tangible assets: 13622759
Owner earnings: 1571675
Return on net tangible assets (%): 11.53712695056853
Capex to operating income (%): 25.59678373223357
Buffett classification: The Good
Stock price: 1.8
P/E ratio: 6.564128185137615
Shares outstanding: 5201386
Book value: 13622759
P/B ratio: 0.6872686215765836
Market cap (USD): 9362494.8
Debt to equity: 0.27867453281673704
Current ratio: 2.7217032068934155
Quick ratio: 0.5145002937255791
Effective tax rate (%): 20.993400430731178
Interest coverage ratio: 5.123653001023418
COGS to revenue (%): 67.4944332135547
R&D to revenue (%): 1.3274280420850633
SG&A to revenue (%): 23.119451953622473
Free cash flow (dilution-adjusted): 1163522
Buyback yield (%): 0
Retained earnings: 8754941
Inventory turnover: 0.39689970204540675
Receivables turnover: 2.9105248846664744
Capitalized R&D asset: 141219.1
ROCI (R&D-adjusted, %): 3.335644359299998
Rosenberg metric: 6.608799718409011
FCF margin (%): 18.361668315792627
Revenue growth (%): 23.259005379350725
Rule of 40 score: 41.62067369514335
Financial ratios for ARTW — quarterly report dated 2025-08-31
Total revenue: 6432296
Gross profit: 1766165
Operating income: 344729
Net income: 254110
Capital expenditures: 261329
Operating cash flow: -1267365
Depreciation & amortization: 196019
Net tangible assets: 13913809
Owner earnings: 188800
Return on net tangible assets (%): 1.3569253394235898
Capex to operating income (%): 75.80708324509978
Buffett classification: The Gruesome
Stock price: 3.15
P/E ratio: 9.750149605277722
Shares outstanding: 5201386
Book value: 13913809
P/B ratio: 1.177561507420434
Market cap (USD): 16384365.9
Debt to equity: 0.38538483602872514
Current ratio: 2.5392817679459085
Quick ratio: 0.5270233659895777
Effective tax rate (%): 20.901334445630756
Interest coverage ratio: 4.120201271692881
COGS to revenue (%): 72.54223064361466
R&D to revenue (%): 1.3578199759463805
SG&A to revenue (%): 20.74060335531823
Free cash flow (dilution-adjusted): -1565635
Buyback yield (%): 0
Retained earnings: 9009051
Inventory turnover: 0.4152122336990171
Receivables turnover: 2.39749914179295
Capitalized R&D asset: 171821.94999999998
ROCI (R&D-adjusted, %): 2.112482162201903
Rosenberg metric: -3.4906021518159664
FCF margin (%): -24.340220039625045
Revenue growth (%): 1.508768773602622
Rule of 40 score: -22.831451266022423
Financial ratios for ARTW — quarterly report dated 2025-11-30
Total revenue: 5065467
Gross profit: 944250
Operating income: -568413
Net income: -645524
Capital expenditures: 152845
Operating cash flow: -889151
Depreciation & amortization: 198158
Net tangible assets: 13306260
Owner earnings: -600211
Return on net tangible assets (%): -4.510741560739081
Buffett classification: The Gruesome
Stock price: 2.36
P/E ratio: 11.861334121816835
Shares outstanding: 5201386
Book value: 13306260
P/B ratio: 0.9225184958057334
Market cap (USD): 12275270.959999999
Debt to equity: 0.48148525581192614
Current ratio: 2.295969206767652
Quick ratio: 0.47736515379374894
Interest coverage ratio: -5.279655585588096
COGS to revenue (%): 81.35907311211385
R&D to revenue (%): 1.7230395539049017
SG&A to revenue (%): 28.139221911819778
Free cash flow (dilution-adjusted): -1079971
Buyback yield (%): 0
Retained earnings: 8363527
Inventory turnover: 0.35199280985138504
Receivables turnover: 1.96227472722441
Capitalized R&D asset: 173555.08000000002
ROCI (R&D-adjusted, %): -3.4995074583463315
Rosenberg metric: -9.410629844628401
FCF margin (%): -21.32026523911813
Revenue growth (%): -21.249472972014967
Rule of 40 score: -42.5697382111331
Financial ratios for ARTW — annual report dated 2025-11-30
Total revenue: 22975408
Gross profit: 6266701
Operating income: 289455
Net income: 1034899
Capital expenditures: 627615
Operating cash flow: -904143
Depreciation & amortization: 853021
Net tangible assets: 13306260
Owner earnings: 1260305
Return on net tangible assets (%): 9.47151942018268
Capex to operating income (%): 216.82644970720838
Buffett classification: The Gruesome
Stock price: 2.36
P/E ratio: 11.86132266047218
Shares outstanding: 5201386
Book value: 13306260
P/B ratio: 0.9225184958057334
Market cap (USD): 12275270.959999999
Debt to equity: 0.48148525581192614
Current ratio: 2.295969206767652
Quick ratio: 0.47736515379374894
Effective tax rate (%): 27.98583513618268
Interest coverage ratio: 0.7893875636448922
COGS to revenue (%): 72.72431027122566
R&D to revenue (%): 1.4970963736530816
SG&A to revenue (%): 24.51874630474462
Free cash flow (dilution-adjusted): -1710838
Buyback yield (%): 0.012561840834509775
Retained earnings: 8363527
Inventory turnover: 1.427089310248285
Receivables turnover: 8.900277598505632
Capitalized R&D asset: 831158.74
ROCI (R&D-adjusted, %): 1.0385693458101324
Rosenberg metric: -2.411454805622915
FCF margin (%): -7.446387894395608
Revenue growth (%): -6.220416842538529
Rule of 40 score: -13.666804736934136
Financial ratios for ASM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 175271023
Market cap (USD): 150733079.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASM — annual report dated 2022-12-31
Total revenue: 32490441.176470585
Gross profit: 11075000
Operating income: 6480147.058823529
Net income: 2276470.588235294
Capital expenditures: 5761764.705882353
Operating cash flow: 8699264.705882352
Depreciation & amortization: 1607352.9411764704
Net tangible assets: 72074264.70588234
Owner earnings: -1877941.1764705884
Return on net tangible assets (%): -2.6055641138123473
Capex to operating income (%): 88.91410416430274
Buffett classification: The Gruesome
Stock price: 0.68
P/E ratio: 52.35485854987081
Shares outstanding: 175271023
Book value: 72074264.70588234
P/B ratio: 1.653631793905388
Market cap (USD): 119184295.64000002
Debt to equity: 0.06776098999194051
Current ratio: 1.5261870675256504
Quick ratio: 1.1527678358387021
Effective tax rate (%): 59.68750000000001
Interest coverage ratio: 89.020202020202
COGS to revenue (%): 65.91305134994455
SG&A to revenue (%): 13.725756444203046
Free cash flow (dilution-adjusted): 1449264.705882353
Buyback yield (%): 0
Retained earnings: -38254411.76470588
Inventory turnover: 4.65255591054313
Receivables turnover: 6.894523326572007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.438984219396353
FCF margin (%): 4.460587955733588
Rule of 40 score: 4.460587955733588
Financial ratios for ASM — annual report dated 2023-12-31
Total revenue: 33249242.424242422
Gross profit: 5923484.848484849
Operating income: -90151.51515151515
Net income: 410606.0606060606
Capital expenditures: 5587121.212121212
Operating cash flow: 1127272.7272727273
Depreciation & amortization: 2211363.6363636362
Net tangible assets: -38956818.18181818
Owner earnings: -2965151.515151515
Buffett classification: The Gruesome
Stock price: 0.52
P/E ratio: 221.96684536383765
Shares outstanding: 175271023
Book value: 80303787.87878788
P/B ratio: 1.1349518418430016
Market cap (USD): 91140931.96000001
Debt to equity: 0.03258459825850699
Current ratio: 1.704446697566628
Quick ratio: 1.065252027809965
Interest coverage ratio: -0.3123359580052493
COGS to revenue (%): 82.18460206429857
SG&A to revenue (%): 17.974891202807083
Free cash flow (dilution-adjusted): -6178787.878787878
Buyback yield (%): 0
Retained earnings: -38956818.18181818
Inventory turnover: 4.08678903240426
Receivables turnover: 4.367064676616915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1039010931442741
FCF margin (%): -18.58324409305293
Revenue growth (%): 2.335459970058384
Rule of 40 score: -16.247784122994545
Financial ratios for ASM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1
Shares outstanding: 175271023
Market cap (USD): 192798125.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.88
Shares outstanding: 175271023
Market cap (USD): 154238500.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASM — annual report dated 2024-12-31
Total revenue: 46278321.67832168
Gross profit: 16224475.524475526
Operating income: 10309790.20979021
Net income: 5664335.664335664
Capital expenditures: 3115384.6153846155
Operating cash flow: 16170629.370629372
Depreciation & amortization: 2367832.167832168
Net tangible assets: -30295804.195804197
Owner earnings: 4916783.216783216
Return on net tangible assets (%): -16.22925466842093
Capex to operating income (%): 30.217730448348373
Buffett classification: The Good
Stock price: 0.88
P/E ratio: 27.22975991891358
Shares outstanding: 175271023
Book value: 87691608.39160839
P/B ratio: 1.7588741165655228
Market cap (USD): 154238500.24
Debt to equity: 0.020965079466343434
Current ratio: 2.624501094373632
Quick ratio: 2.1345435818205227
Effective tax rate (%): 43.831911795298524
Interest coverage ratio: 38.09560723514212
COGS to revenue (%): 64.94152135150654
SG&A to revenue (%): 12.483000392879807
Free cash flow (dilution-adjusted): 11632167.832167832
Buyback yield (%): 0
Retained earnings: -30295804.195804197
Inventory turnover: 5.6466955721981344
Receivables turnover: 18.573673870333987
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.070229844492667
FCF margin (%): 25.135241318867298
Revenue growth (%): 39.186093589247015
Rule of 40 score: 64.32133490811431
Financial ratios for ASM — quarterly report dated 2025-03-31
Total revenue: 13172027.972027972
Gross profit: 7386013.986013986
Operating income: 5614685.314685315
Net income: 3927972.027972028
Capital expenditures: 969230.7692307692
Operating cash flow: 530069.93006993
Depreciation & amortization: 609790.2097902098
Net tangible assets: 92509090.9090909
Owner earnings: 3568531.468531469
Return on net tangible assets (%): 3.857492743105951
Capex to operating income (%): 17.26242371403662
Buffett classification: The Great
Stock price: 1.84
P/E ratio: 20.52577513430657
Shares outstanding: 175271023
Book value: 92509090.9090909
P/B ratio: 3.4861296241352204
Market cap (USD): 322498682.32
Debt to equity: 0.03801554184808902
Current ratio: 3.113216453135536
Quick ratio: 2.4469993256911664
Effective tax rate (%): 36.57407407407407
Interest coverage ratio: 99.12345679012346
COGS to revenue (%): 43.92652367806328
SG&A to revenue (%): 12.996389891696753
Free cash flow (dilution-adjusted): -692307.6923076923
Buyback yield (%): 0
Retained earnings: -26367832.16783217
Inventory turnover: 0.8374493927125506
Receivables turnover: 2.8674075201704974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.620069577147337
FCF margin (%): -5.255892970906774
Rule of 40 score: -5.255892970906774
Financial ratios for ASM — quarterly report dated 2025-06-30
Total revenue: 16015328.467153283
Gross profit: 7462773.722627737
Operating income: 5021167.883211679
Net income: 2090510.9489051094
Capital expenditures: 2861313.8686131383
Operating cash flow: 6094890.510948905
Depreciation & amortization: 674452.5547445255
Net tangible assets: 105673722.62773722
Owner earnings: -96350.36496350355
Return on net tangible assets (%): -0.09117722227210866
Capex to operating income (%): 56.9850268934438
Buffett classification: The Good
Stock price: 3.6
P/E ratio: 104.8396556448183
Shares outstanding: 175271023
Book value: 105673722.62773722
P/B ratio: 5.970979985466904
Market cap (USD): 630975682.8000001
Debt to equity: 0.03763132628321579
Current ratio: 3.190432531549995
Quick ratio: 2.6232876712328768
Effective tax rate (%): 56.01290124404853
Interest coverage ratio: 60.3421052631579
COGS to revenue (%): 52.782462057335586
SG&A to revenue (%): 14.830682284307917
Free cash flow (dilution-adjusted): 2270072.9927007295
Buyback yield (%): 0
Retained earnings: -25432116.788321167
Inventory turnover: 1.1012742487637885
Receivables turnover: 2.9835463693228172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.4057180186757865
FCF margin (%): 14.17437673761451
Revenue growth (%): 21.585897791618144
Rule of 40 score: 35.76027452923265
Financial ratios for ASM — quarterly report dated 2025-09-30
Total revenue: 15413669.064748203
Gross profit: 7125899.28057554
Operating income: 4929496.402877699
Net income: 5541007.194244605
Capital expenditures: 12195683.45323741
Operating cash flow: 5992086.330935252
Depreciation & amortization: 676258.9928057555
Net tangible assets: 131023021.58273382
Owner earnings: -5978417.26618705
Return on net tangible assets (%): -4.562875435147867
Capex to operating income (%): 247.40221833041446
Buffett classification: The Gruesome
Stock price: 5.25
P/E ratio: 79.60324003292142
Shares outstanding: 175271023
Book value: 131023021.58273382
P/B ratio: 7.022986186965331
Market cap (USD): 920172870.75
Debt to equity: 0.02563117031440463
Current ratio: 2.7543344615597154
Quick ratio: 2.3398839538578438
Effective tax rate (%): 28.05903231832617
Interest coverage ratio: 253.77777777777777
COGS to revenue (%): 51.981330221703615
SG&A to revenue (%): 13.778296382730455
Free cash flow (dilution-adjusted): -7041726.618705036
Buyback yield (%): 0
Retained earnings: -19478417.266187053
Inventory turnover: 0.9280833333333333
Receivables turnover: 3.4848731294729993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5520258781570115
FCF margin (%): -45.684947491248536
Revenue growth (%): -3.7567721676083994
Rule of 40 score: -49.44171965885693
Financial ratios for ASM — quarterly report dated 2025-12-31
Total revenue: 24160583.941605836
Gross profit: 13024817.518248174
Operating income: 10332116.788321167
Net income: 7635036.496350365
Capital expenditures: 2949635.03649635
Operating cash flow: 7289051.094890511
Depreciation & amortization: 736496.3503649634
Net tangible assets: -12127737.226277372
Owner earnings: 5421897.810218979
Return on net tangible assets (%): -44.70659043033404
Capex to operating income (%): 28.548216178028962
Buffett classification: The Good
Stock price: 6.21
P/E ratio: 56.70538647220234
Shares outstanding: 175271023
Book value: 170824817.51824814
P/B ratio: 6.371633048656584
Market cap (USD): 1088433052.83
Debt to equity: 0.025697560141862155
Current ratio: 4.062880698947886
Quick ratio: 3.687688426751984
Effective tax rate (%): 24.33996383363472
Interest coverage ratio: 144.4387755102041
COGS to revenue (%): 38.368580060422964
SG&A to revenue (%): 11.746223564954683
Free cash flow (dilution-adjusted): 3697810.218978102
Buyback yield (%): 0
Retained earnings: -12127737.226277372
Inventory turnover: 1.041325024598229
Receivables turnover: 2.3788989506971396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.741787884442209
FCF margin (%): 15.305135951661633
Revenue growth (%): 56.74777913107169
Rule of 40 score: 72.05291508273332
Financial ratios for ASM — annual report dated 2025-12-31
Total revenue: 67318978.10218978
Gross profit: 35427007.29927007
Operating income: 26215328.46715328
Net income: 19447445.255474452
Capital expenditures: 19196350.3649635
Operating cash flow: 20016788.321167883
Depreciation & amortization: 2733576.642335766
Net tangible assets: -12127737.226277372
Owner earnings: 2984671.5328467153
Return on net tangible assets (%): -24.610291904905207
Capex to operating income (%): 73.22567172490602
Buffett classification: The Good
Stock price: 6.21
P/E ratio: 55.967919617802046
Shares outstanding: 175271023
Book value: 170824817.51824814
P/B ratio: 6.371633048656584
Market cap (USD): 1088433052.83
Debt to equity: 0.025697560141862155
Current ratio: 4.062880698947886
Quick ratio: 3.687688426751984
Effective tax rate (%): 33.22221665246378
Interest coverage ratio: 113.65506329113923
COGS to revenue (%): 47.3744131328136
SG&A to revenue (%): 13.462435078664598
Free cash flow (dilution-adjusted): -1899270.0729927006
Buyback yield (%): 0
Retained earnings: -12127737.226277372
Inventory turnover: 3.582486061003608
Receivables turnover: 6.628359925255139
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.568443085110697
FCF margin (%): -2.821299619417307
Revenue growth (%): 45.46546992373807
Rule of 40 score: 42.64417030432076
Financial ratios for AUG.AX — annual report dated 2022-06-30
Operating income: -280307.5862068966
Net income: -281140
Capital expenditures: 24237.93103448276
Depreciation & amortization: 4565.517241379311
Net tangible assets: 1080352.4137931035
Owner earnings: -300812.4137931035
Return on net tangible assets (%): -27.84391555501366
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 257949323
Book value: 1080352.4137931033
P/B ratio: 6.586594616954495
Market cap (USD): 7115843.393103449
Debt to equity: 0.5279337329900653
Current ratio: 0.6265845897021232
Quick ratio: 0.6265845897021232
Interest coverage ratio: -336.7406793703397
Free cash flow (dilution-adjusted): -228296.55172413794
Buyback yield (%): 0
Retained earnings: -312751.0344827586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.06404801239355
Rule of 40 score: 0
Financial ratios for AUG.AX — annual report dated 2023-06-30
Operating income: -1248238.4105960266
Net income: -1197749.6688741723
Capital expenditures: 25737.08609271523
Depreciation & amortization: 205.2980132450331
Net tangible assets: 9619773.509933775
Owner earnings: -1223281.4569536424
Return on net tangible assets (%): -12.716322849913581
Buffett classification: The Gruesome
Stock price: 0.18543046357615894
Shares outstanding: 257949323
Book value: 9619773.509933773
P/B ratio: 4.972223357821618
Market cap (USD): 47831662.543046355
Debt to equity: 0.0010583195842889283
Current ratio: 25.557755183528446
Quick ratio: 25.557755183528446
Interest coverage ratio: -910.5507246376812
Free cash flow (dilution-adjusted): -1275011.2582781457
Buyback yield (%): 0
Retained earnings: -1498073.5099337748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.972641714224443
Rule of 40 score: 0
Financial ratios for AUG.AX — annual report dated 2024-06-30
Operating income: -787269.3333333334
Net income: -634500
Capital expenditures: 153202.66666666666
Depreciation & amortization: 2158
Net tangible assets: 9049405.333333334
Owner earnings: -785544.6666666666
Return on net tangible assets (%): -8.680621960573761
Buffett classification: The Gruesome
Stock price: 0.02666666666666667
Shares outstanding: 257949323
Book value: 9047305.333333332
P/B ratio: 0.7602980511766377
Market cap (USD): 6878648.613333334
Debt to equity: 0.00046422662276310935
Current ratio: 10.708823037457032
Quick ratio: 10.708823037457032
Interest coverage ratio: -2455.101871101871
Free cash flow (dilution-adjusted): -3802667.3333333335
Buyback yield (%): 0
Retained earnings: -2142560.6666666665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.699803358146612
Rule of 40 score: 0
Financial ratios for BCF.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.338582677165355
Shares outstanding: 2246824
Market cap (USD): 11994855.685039371
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCF.V — annual report dated 2022-12-31
Total revenue: 2336530.147058823
Net income: 1991308.088235294
Capital expenditures: 0
Net tangible assets: 21521930.88235294
Owner earnings: 1991308.088235294
Return on net tangible assets (%): 9.25246019569778
Buffett classification: The Gruesome
Stock price: 4.999999999999999
P/E ratio: 5.641578049309148
Shares outstanding: 2246824
Book value: 21521930.88235294
P/B ratio: 0.5219847634215522
Market cap (USD): 11234119.999999998
Debt to equity: 0.19534328629080336
COGS to revenue (%): 0
SG&A to revenue (%): 3.6641500515627596
Free cash flow (dilution-adjusted): -1751341.1764705882
Buyback yield (%): 0
Retained earnings: 184584.5588235294
Receivables turnover: 5555.386363636363
Capitalized R&D asset: 0
FCF margin (%): -74.95478621044718
Rule of 40 score: -74.95478621044718
Financial ratios for BCF.V — annual report dated 2023-12-31
Total revenue: 2855382.5757575757
Net income: 2495043.9393939395
Capital expenditures: 0
Net tangible assets: 22254976.515151516
Owner earnings: 2495043.9393939395
Return on net tangible assets (%): 11.211173095128979
Buffett classification: The Gruesome
Stock price: 5.181818181818182
P/E ratio: 4.666303975942611
Shares outstanding: 2246824
Book value: 22254976.515151512
P/B ratio: 0.5231474158878119
Market cap (USD): 11642633.454545455
Debt to equity: 0.11234228884932071
COGS to revenue (%): 0
SG&A to revenue (%): 3.5493572081435776
Free cash flow (dilution-adjusted): 3951097.727272727
Buyback yield (%): 0.8217837751296628
Retained earnings: 308006.0606060606
Capitalized R&D asset: 0
FCF margin (%): 138.37367226437044
Revenue growth (%): 22.206108889794272
Rule of 40 score: 160.57978115416472
Financial ratios for BCF.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.659259259259259
Shares outstanding: 2246824
Market cap (USD): 12715359.525925925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCF.V — quarterly report dated 2024-12-31
Total revenue: 776026.5734265734
Net income: 566986.0139860141
Capital expenditures: 0
Net tangible assets: 20427430.06993007
Owner earnings: 566986.0139860141
Return on net tangible assets (%): 2.775611087860917
Buffett classification: The Gruesome
Stock price: 5.538461538461538
P/E ratio: 5.4868850380493095
Shares outstanding: 2246824
Book value: 20427430.06993007
P/B ratio: 0.6091783579771133
Market cap (USD): 12443948.307692308
Debt to equity: 0.45960670940708587
COGS to revenue (%): 0
SG&A to revenue (%): 4.488798055001361
Free cash flow (dilution-adjusted): 1234018.8811188813
Buyback yield (%): 0
Retained earnings: 308548.2517482518
Receivables turnover: 265.4827751196172
Capitalized R&D asset: 0
FCF margin (%): 159.0176062747473
Rule of 40 score: 159.0176062747473
Financial ratios for BCF.V — annual report dated 2024-12-31
Total revenue: 2913419.5804195805
Net income: 2292484.6153846155
Capital expenditures: 0
Net tangible assets: 20427430.06993007
Owner earnings: 2292484.6153846155
Return on net tangible assets (%): 11.222579676134774
Buffett classification: The Gruesome
Stock price: 5.538461538461538
P/E ratio: 5.428149102586041
Shares outstanding: 2246824
Book value: 20427430.06993007
P/B ratio: 0.6091783579771133
Market cap (USD): 12443948.307692308
Debt to equity: 0.45960670940708587
COGS to revenue (%): 0
SG&A to revenue (%): 3.3321091932917124
Free cash flow (dilution-adjusted): 384032.1678321679
Buyback yield (%): 1.0429986253637773
Retained earnings: 308548.2517482518
Receivables turnover: 996.6961722488038
Capitalized R&D asset: 0
FCF margin (%): 13.181491962680534
Revenue growth (%): 2.0325474125514225
Rule of 40 score: 15.214039375231955
Financial ratios for BCF.V — quarterly report dated 2025-03-31
Total revenue: 804827.2727272727
Net income: 643366.4335664336
Capital expenditures: 0
Net tangible assets: 20506811.18881119
Owner earnings: 643366.4335664336
Return on net tangible assets (%): 3.1373304588548785
Buffett classification: The Gruesome
Stock price: 5.5874125874125875
P/E ratio: 4.87822026621334
Shares outstanding: 2246824
Book value: 20506811.18881119
P/B ratio: 0.6121835610477705
Market cap (USD): 12553932.699300699
Debt to equity: 0.757084939201507
COGS to revenue (%): 0
SG&A to revenue (%): 2.657826072223289
Free cash flow (dilution-adjusted): -2093351.7482517483
Buyback yield (%): 0
Retained earnings: 387929.3706293706
Capitalized R&D asset: 0
FCF margin (%): -260.0995044760506
Revenue growth (%): 3.71130323199227
Rule of 40 score: -256.38820124405834
Financial ratios for BCF.V — quarterly report dated 2025-06-30
Total revenue: 876308.0291970802
Net income: 698413.1386861313
Capital expenditures: 0
Net tangible assets: 21514647.445255473
Owner earnings: 698413.1386861313
Return on net tangible assets (%): 3.246221628605628
Buffett classification: The Gruesome
Stock price: 6.109489051094889
P/E ratio: 7.19153086513237
Shares outstanding: 2246824
Book value: 21514647.445255473
P/B ratio: 0.6380279603774945
Market cap (USD): 13726946.627737224
Debt to equity: 0.6454678796828519
COGS to revenue (%): 0
SG&A to revenue (%): 3.6413553211799337
Free cash flow (dilution-adjusted): 3224090.510948905
Buyback yield (%): 0
Retained earnings: 514646.71532846714
Receivables turnover: 45.21815442561205
Capitalized R&D asset: 0
FCF margin (%): 367.91749060007896
Revenue growth (%): 8.881502763640784
Rule of 40 score: 376.7989933637198
Financial ratios for BCF.V — quarterly report dated 2025-09-30
Total revenue: 921732.3741007195
Net income: 660805.035971223
Capital expenditures: 0
Net tangible assets: 21285673.381294966
Owner earnings: 660805.035971223
Return on net tangible assets (%): 3.1044591549164386
Buffett classification: The Gruesome
Stock price: 6.294964028776979
P/E ratio: 5.5042955958258135
Shares outstanding: 2246824
Book value: 21285673.381294962
P/B ratio: 0.6644692890675346
Market cap (USD): 14143676.258992808
Debt to equity: 0.7629999453139793
COGS to revenue (%): 0
SG&A to revenue (%): 2.941676917409195
Free cash flow (dilution-adjusted): -1715312.9496402878
Buyback yield (%): 0
Retained earnings: 587830.9352517986
Receivables turnover: 48.25642184557439
Capitalized R&D asset: 0
FCF margin (%): -186.09663692390305
Revenue growth (%): 5.183604781672431
Rule of 40 score: -180.9130321422306
Financial ratios for BDCI — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -443165
Net income: 1969390
Capital expenditures: 0
Operating cash flow: -745838
Net tangible assets: 246407354
Owner earnings: 1969390
Return on net tangible assets (%): 0.7992415680905368
Buffett classification: The Gruesome
Stock price: 10.01
P/E ratio: 139.4020038657969
Shares outstanding: 26060000
Book value: 246407354
P/B ratio: 1.0586559035896306
Market cap (USD): 260860600
Debt to equity: 0
Current ratio: 22.75348088863219
Quick ratio: 22.75348088863219
Free cash flow (dilution-adjusted): -745838
Buyback yield (%): 0
Retained earnings: -8606146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.17231212697961812
Rule of 40 score: 0
Financial ratios for BDCI — annual report dated 2025-12-31
Total revenue: 0
Operating income: -541272
Net income: 1871283
Capital expenditures: 0
Operating cash flow: -745838
Net tangible assets: 246407354
Owner earnings: 1871283
Return on net tangible assets (%): 0.759426603801768
Buffett classification: The Gruesome
Stock price: 10.01
P/E ratio: 139.4020038657969
Shares outstanding: 26060000
Book value: 246407354
P/B ratio: 1.0586559035896306
Market cap (USD): 260860600
Debt to equity: 0
Current ratio: 22.75348088863219
Quick ratio: 22.75348088863219
Free cash flow (dilution-adjusted): -745838
Buyback yield (%): 0
Retained earnings: -8606146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21045824826985857
Rule of 40 score: 0
Financial ratios for BDGI.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.055118110236222
Shares outstanding: 33659562
Market cap (USD): 776025177.4488189
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BDGI.TO — annual report dated 2022-12-31
Total revenue: 419714705.8823529
Gross profit: 102316176.47058822
Operating income: 25636029.411764704
Net income: 13448529.411764706
Capital expenditures: 45846323.52941176
Operating cash flow: 50241911.76470588
Depreciation & amortization: 43811764.70588235
Net tangible assets: 146925000
Owner earnings: 11413970.588235289
Return on net tangible assets (%): 7.768569398152316
Capex to operating income (%): 178.83550838950237
Buffett classification: The Gruesome
Stock price: 18.477941176470587
P/E ratio: 46.24739163805358
Shares outstanding: 33659562
Book value: 163858088.2352941
P/B ratio: 3.795719902264783
Market cap (USD): 621959406.6617646
Debt to equity: 0.7448563364101828
Current ratio: 1.7411173837616096
Quick ratio: 1.4994584647235296
Effective tax rate (%): 20.071668924529128
Interest coverage ratio: 4.613603281725553
COGS to revenue (%): 75.62244661990289
SG&A to revenue (%): 7.831124783641549
Free cash flow (dilution-adjusted): -2645588.2352941176
Buyback yield (%): 0
Retained earnings: 117157352.94117646
Inventory turnover: 17.12061238250109
Receivables turnover: 4.034149616594226
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.133352928963507
FCF margin (%): -0.6303301262061766
Rule of 40 score: -0.6303301262061766